Captain Capitalism update. Last month's pick, OSI Pharmaceuticals, just released the results of its phase III trials on its new drug for lung cancer and it looks promising. With 173,000 Americans getting lung cancer every year, the market potential is huge. As a result, OSI, which finished Friday at $38.14, last went for $80.35 in pre-market trading. Honestly, I thought this was a good company but I never envisioned anything like this. Amazing.